ABO-102

unlisted · Ultragenyx Pharmaceutical Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABO-102, covering 2023-07-25 to 2023-07-25. Get the full timeline:

Most recent: Clinical Trial Update: Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease [Phase 1, Phase 2]